Thrombin-induced MCP-1 expression involves activation of the P22phox-containing NADPH oxidase in human vascular smooth muscle cells

Thrombosis and Haemostasis

Volumn 85, Issue 6, 2001, Pages 1104-1110

  Brandes, R P ^a   Viedt, C ^a   Nguyen, K ^a   Beer, S ^a   Kreuzer, J ^a   Busse, R ^a   Gorlach A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

MCP 1; NADPH oxidase; Oxidative stress; p22phox; Thrombin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; ASCORBIC ACID; CHEMOKINE; DIPHENYLIODONIUM SALT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOCYTE CHEMOTACTIC PROTEIN; NEUTRALIZING ANTIBODY; PROTEIN SUBUNIT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SYNAPTOPHYSIN; THROMBIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034975449     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615970     Document Type: Article

References (51)

1. Thrombin hypothesis of thrombus generation and vascular lesion formation
2. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
3. Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells
4. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
5. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells
6. Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells
7. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo
8. The role of reactive oxygen species in atherosclerosis
9. Atherosclerosis as disease of redox-sensitive genes
10. Oxidative stress and atherosclerosis: Its relationship to growth factors, thrombus formation and therapeutic approaches
11. p22phox is a critical of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
12. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats
13. Glucocorticoids inhibit superoxide anion production and p22phox mRNA expression in human aortic smooth muscle cells
14. Oxidative stress and expression of p22phox are involved in the upregulation of tissue factor in vascular smooth muscle cells ion response to activated platelets
15. Tumor necrosis factor alpha activates a p22 phox-based NADH oxidase in vascular smooth muscle cells
16. Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia
17. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: Role of a superoxide-producing NADH oxidase
18. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy
19. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptor
20. Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-gamma 1 in rat aortic smooth muscle cells
21. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall
22. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases
23. Cellular consequences of thrombin-receptor activation
24. Activation of the neutrophil respiratory burst oxidase
25. NADPH oxidase and the respiratory burst
26. Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species
27. Neuronal nitric oxide synthase catalyzes the reduction of 7-ethoxyresorufin
28. Oxygen radical stress in vascular disease: The role of endothelial nitric oxide synthase
29. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase
30. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils
31. Inducible nitric-oxide synthase generates superoxide from the reductase domain
32. NADH oxidase activity of human xanthine oxidoreductase-generation of superoxide anion
33. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production
34. NADH-oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium
35. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle
36. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells
37. Sphingolipid metabolism and signal transduction: Inhibition of in vitro phospholipase activity by sphingosine
38. Activation of NADPH-oxidase mediated production of reactive oxygen species by platelet derived growth factor isoform AA but inhibition by platelet derived growth factor BB in smooth muscle cells
39. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
40. Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor
41. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells
42. Ras, superoxide and signal transduction
43. The stress-activated protein kinase pathways
44. MAP kinases and vascular smooth muscle function
45. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: Involvement of p22phox and reactive oxygen species
46. Redox-sensitive protein phosphatase activity regulates the phosphorylation state of p38 protein kinase in primary astrocyte culture
47. Regulation of tyrosine phosphorylation in isolated T cell membrane by inhibition of protein tyrosine phosphatases
48. Regulation of PTP1B via glutathionylation of the active site cysteine 215
49. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: Evidence for a sulfenic acid intermediate and implications for redox regulation
50. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells
51. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells